WATSON 605 (Labetalol Hydrochloride 100 mg)

Pill with imprint WATSON 605 is Beige, Round and has been identified as Labetalol Hydrochloride 100 mg. It is supplied by Watson Laboratories, Inc..

Labetalol is used in the treatment of hypertensive emergency; high blood pressure; postural orthostatic tachycardia syndrome; pheochromocytoma; mitral valve prolapse and belongs to the drug class non-cardioselective beta blockers. Risk cannot be ruled out during pregnancy. Labetalol 100 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for WATSON 605

Labetalol Hydrochloride

Imprint:

WATSON 605

Strength:

100 mg

Color:

Beige

Size:

8.00 mm

Shape:

Round

Availability:

Prescription only

Drug Class:

Non-cardioselective beta blockers

Pregnancy Category:

C - Risk cannot be ruled out

CSA Schedule:

Not a controlled drug

Labeler / Supplier:

Watson Laboratories, Inc.

Inactive Ingredients:

lactose anhydrous
silicon dioxide colloidal
crospovidone
hypromelloses
magnesium stearate
microcrystalline cellulose
polyethylene glycol
polysorbate 80
corn starch
water
titanium dioxide
ferric oxide red
ferric oxide yellow
Note: Inactive ingredients may vary.

Other Labelers / Repackagers:

NDC Code	Labeler / Repackager
00904-5928	Major Pharmaceuticals
60429-0277	Golden State Medical Supply (repackager)

More Info Imprint SearchPrint

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer